• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MiRSEA:发现由功能失调的微小RNA调控的信号通路

MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs.

作者信息

Han Junwei, Liu Siyao, Zhang Yunpeng, Xu Yanjun, Jiang Ying, Zhang Chunlong, Li Chunquan, Li Xia

机构信息

College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, 150081, PR China.

College of Basic Medical Science, Heilongjiang University of Chinese Medicine, Harbin 150040, PR China.

出版信息

Oncotarget. 2016 Aug 23;7(34):55012-55025. doi: 10.18632/oncotarget.10839.

DOI:10.18632/oncotarget.10839
PMID:27474169
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5342398/
Abstract

Recent studies have shown that dysfunctional microRNAs (miRNAs) are involved in the progression of various cancers. Dysfunctional miRNAs may jointly regulate their target genes and further alter the activities of canonical biological pathways. Identification of the pathways regulated by a group of dysfunctional miRNAs could help uncover the pathogenic mechanisms of cancer and facilitate development of new drug targets. Current miRNA-pathway analyses mainly use differentially-expressed miRNAs to predict the shared pathways on which they act. However, these methods fail to consider the level of differential expression level, which could improve our understanding of miRNA function. We propose a novel computational method, MicroRNA Set Enrichment Analysis (MiRSEA), to identify the pathways regulated by dysfunctional miRNAs. MiRSEA integrates the differential expression levels of miRNAs with the strength of miRNA pathway associations to perform direct enrichment analysis using miRNA expression data. We describe the MiRSEA methodology and illustrate its effectiveness through analysis of data from hepatocellular cancer, gastric cancer and lung cancer. With these analyses, we show that MiRSEA can successfully detect latent biological pathways regulated by dysfunctional miRNAs. We have implemented MiRSEA as a freely available R-based package on CRAN (https://cran.r-project.org/web/packages/MiRSEA/).

摘要

近期研究表明,功能失调的微小RNA(miRNA)参与了多种癌症的进展。功能失调的miRNA可能共同调控其靶基因,并进一步改变经典生物学途径的活性。鉴定一组功能失调的miRNA所调控的途径有助于揭示癌症的致病机制,并促进新药物靶点的开发。目前的miRNA-途径分析主要使用差异表达的miRNA来预测它们所作用的共同途径。然而,这些方法没有考虑差异表达水平,而这可能会增进我们对miRNA功能的理解。我们提出了一种新的计算方法,即微小RNA集富集分析(MiRSEA),以鉴定功能失调的miRNA所调控的途径。MiRSEA将miRNA的差异表达水平与miRNA途径关联强度相结合,利用miRNA表达数据进行直接富集分析。我们描述了MiRSEA方法,并通过对肝细胞癌、胃癌和肺癌数据的分析来说明其有效性。通过这些分析,我们表明MiRSEA能够成功检测出由功能失调的miRNA调控的潜在生物学途径。我们已将MiRSEA作为一个基于R的免费软件包在CRAN(https://cran.r-project.org/web/packages/MiRSEA/)上实现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/797d6ee894f1/oncotarget-07-55012-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/bc6b93aa86f8/oncotarget-07-55012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/d0b1007f131c/oncotarget-07-55012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/48bd41819577/oncotarget-07-55012-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/797d6ee894f1/oncotarget-07-55012-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/bc6b93aa86f8/oncotarget-07-55012-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/d0b1007f131c/oncotarget-07-55012-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/48bd41819577/oncotarget-07-55012-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f569/5342398/797d6ee894f1/oncotarget-07-55012-g004.jpg

相似文献

1
MiRSEA: Discovering the pathways regulated by dysfunctional MicroRNAs.MiRSEA:发现由功能失调的微小RNA调控的信号通路
Oncotarget. 2016 Aug 23;7(34):55012-55025. doi: 10.18632/oncotarget.10839.
2
Integrated analyses to reconstruct microRNA-mediated regulatory networks in mouse liver using high-throughput profiling.利用高通量分析重建小鼠肝脏中微小RNA介导的调控网络的综合分析。
BMC Genomics. 2015;16 Suppl 2(Suppl 2):S12. doi: 10.1186/1471-2164-16-S2-S12. Epub 2015 Jan 21.
3
A systems biology approach for miRNA-mRNA expression patterns analysis in non-small cell lung cancer.系统生物学方法分析非小细胞肺癌中 miRNA-mRNA 表达模式。
Cancer Biomark. 2016;16(1):31-45. doi: 10.3233/CBM-150538.
4
Differential regulation analysis reveals dysfunctional regulatory mechanism involving transcription factors and microRNAs in gastric carcinogenesis.差异调控分析揭示了胃癌发生过程中涉及转录因子和微小RNA的功能失调调控机制。
Artif Intell Med. 2017 Mar;77:12-22. doi: 10.1016/j.artmed.2017.02.006. Epub 2017 Mar 1.
5
A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.一种用于推断特定条件下转录因子和微小RNA对蛋白质-蛋白质相互作用的协同调控的新型框架。
Gene. 2016 Feb 10;577(1):55-64. doi: 10.1016/j.gene.2015.11.023. Epub 2015 Nov 27.
6
Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.基于生物信息学分析的肝细胞癌关键基因和微小RNA的鉴定与相互作用分析
World J Surg Oncol. 2017 Mar 16;15(1):63. doi: 10.1186/s12957-017-1127-2.
7
Integrated miRNA profiling and bioinformatics analyses reveal potential causative miRNAs in gastric adenocarcinoma.整合的miRNA谱分析和生物信息学分析揭示了胃腺癌中潜在的致病miRNA。
Oncotarget. 2015 Oct 20;6(32):32878-89. doi: 10.18632/oncotarget.5419.
8
Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer.可重复的组合调控网络揭示了非小细胞肺癌中的新型致癌 microRNA。
RNA. 2014 Sep;20(9):1356-68. doi: 10.1261/rna.042754.113. Epub 2014 Jul 14.
9
Identifying cancer-related microRNAs based on gene expression data.基于基因表达数据识别癌症相关的微小RNA。
Bioinformatics. 2015 Apr 15;31(8):1226-34. doi: 10.1093/bioinformatics/btu811. Epub 2014 Dec 12.
10
Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis.通过通路富集分析鉴定 COPD 和非小细胞肺癌之间的常见 microRNA。
BMC Genom Data. 2021 Oct 12;22(1):41. doi: 10.1186/s12863-021-00986-z.

引用本文的文献

1
Exosomal microRNA panel as a diagnostic biomarker in patients with hepatocellular carcinoma.外泌体微小RNA检测 panel 作为肝细胞癌患者的诊断生物标志物
Front Cell Dev Biol. 2022 Sep 23;10:927251. doi: 10.3389/fcell.2022.927251. eCollection 2022.
2
Identification of common microRNA between COPD and non-small cell lung cancer through pathway enrichment analysis.通过通路富集分析鉴定 COPD 和非小细胞肺癌之间的常见 microRNA。
BMC Genom Data. 2021 Oct 12;22(1):41. doi: 10.1186/s12863-021-00986-z.
3
Intragenic MicroRNAs Autoregulate Their Host Genes in Both Direct and Indirect Ways-A Cross-Species Analysis.

本文引用的文献

1
RETRACTED: Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.撤回:弥漫型胃腺癌中的化疗耐药性由癌症干细胞样细胞中的RhoA激活介导。
Clin Cancer Res. 2016 Feb 15;22(4):971-83. doi: 10.1158/1078-0432.CCR-15-1356. Epub 2015 Oct 19.
2
GnRH participates in the self-renewal of A549-derived lung cancer stem-like cells through upregulation of the JNK signaling pathway.促性腺激素释放激素通过上调JNK信号通路参与A549来源的肺癌干细胞样细胞的自我更新。
Oncol Rep. 2015 Jul;34(1):244-50. doi: 10.3892/or.2015.3956. Epub 2015 May 6.
3
Pathway analysis from lists of microRNAs: common pitfalls and alternative strategy.
基因内 microRNAs 以直接和间接方式调控自身宿主基因——跨物种分析。
Cells. 2020 Jan 17;9(1):232. doi: 10.3390/cells9010232.
4
Analyzing the regulation of miRNAs on protein-protein interaction network in Hodgkin lymphoma.分析 miRNA 对霍奇金淋巴瘤中蛋白质-蛋白质相互作用网络的调控。
BMC Bioinformatics. 2019 Sep 2;20(1):449. doi: 10.1186/s12859-019-3041-9.
5
Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.基于整合通路活性和药物活性构建的药物功能相似性网络对候选癌症药物进行优先级排序。
Mol Oncol. 2019 Oct;13(10):2259-2277. doi: 10.1002/1878-0261.12564. Epub 2019 Aug 21.
6
MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3.MicroRNA-411 通过直接靶向 STAT3 抑制宫颈癌进展。
Oncol Res. 2019 Feb 21;27(3):349-358. doi: 10.3727/096504018X15247361080118. Epub 2018 May 1.
7
miRwayDB: a database for experimentally validated microRNA-pathway associations in pathophysiological conditions.miRwayDB:一个在病理生理条件下经实验验证的 microRNA-通路关联数据库。
Database (Oxford). 2018 Jan 1;2018. doi: 10.1093/database/bay023.
来自微小RNA列表的通路分析:常见陷阱与替代策略
Nucleic Acids Res. 2015 Apr 20;43(7):3490-7. doi: 10.1093/nar/gkv249. Epub 2015 Mar 23.
4
Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.SMYD3和基质金属蛋白酶-9的过表达与胃癌患者的不良预后相关。
Tumour Biol. 2015 Jun;36(6):4377-86. doi: 10.1007/s13277-015-3077-z. Epub 2015 Jan 28.
5
Bias in microRNA functional enrichment analysis.微小RNA功能富集分析中的偏差
Bioinformatics. 2015 May 15;31(10):1592-8. doi: 10.1093/bioinformatics/btv023. Epub 2015 Jan 20.
6
microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.微小RNA-128通过直接靶向血管内皮生长因子-C,在人类非小细胞肺癌的肿瘤发生、血管生成和淋巴管生成中发挥关键作用。
Eur J Cancer. 2014 Sep;50(13):2336-50. doi: 10.1016/j.ejca.2014.06.005. Epub 2014 Jul 4.
7
MiR-182 is up-regulated and targeting Cebpa in hepatocellular carcinoma.miR-182 在肝癌中上调并靶向 Cebpa。
Chin J Cancer Res. 2014 Feb;26(1):17-29. doi: 10.3978/j.issn.1000-9604.2014.01.01.
8
MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer.miR-145、miR-133a 和 miR-133b 通过靶向胃癌中的转录因子 Sp1 抑制增殖、迁移、侵袭和细胞周期进程。
FEBS Lett. 2014 Apr 2;588(7):1168-77. doi: 10.1016/j.febslet.2014.02.054. Epub 2014 Mar 5.
9
Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype.miR-196b 和 HOXA10 的过表达特征为预后不良的胃癌亚型。
World J Gastroenterol. 2013 Nov 7;19(41):7078-88. doi: 10.3748/wjg.v19.i41.7078.
10
Rhamnetin and cirsiliol induce radiosensitization and inhibition of epithelial-mesenchymal transition (EMT) by miR-34a-mediated suppression of Notch-1 expression in non-small cell lung cancer cell lines.瑞香素和瑞香苷通过 miR-34a 介导的 Notch-1 表达抑制诱导非小细胞肺癌细胞系的放射增敏和上皮-间充质转化(EMT)抑制。
J Biol Chem. 2013 Sep 20;288(38):27343-27357. doi: 10.1074/jbc.M113.490482. Epub 2013 Jul 31.